Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2015
- Source ID
- 10.1016/j.bbmt.2014.10.001
Entities
People
- Brent Logan
- Chatchada Karanes
- Dennis L Confer
- Edward L. Snyder
- Eneida Nemecek
- Galen E Switzer
- Ginna G. Laport
- Gregory Hale
- John E. Levine
- John Miller
- Navneet S Majhail
- Pintip Chitphakdithai
- Robert J. Hartzman
- Roberta King
- Steven M Devine
- Susan N. Rossmann
- Willis Navarro
Organizations
- ARIAD Pharmaceuticals
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- CellGenix (Germany)
- Children’s Leukemia Research Association
- Elevance Health, Inc.
- GSK
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)